Search

everythinglearnresearchcommunity

for

Search:↓

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Certain Prakruti types are more prone to early male pattern baldness.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

PROTO1 and PROTO2 protect against hearing damage.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

New alopecia treatments aim for better results and fewer side effects.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

Low-Level Laser Therapy might be an effective alternative hair loss treatment for some people.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.